Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
PMZ-1620, an Endothelin-B Agonist, enters Phase III Trial in Patients with Cerebral Ischemic Stroke
Firstwordpharma News
-
July 18, 2019
Phase III
Polyphor closes the Phase III PRISM studies of murepavadin intravenous formulation and evaluates further product improvement options
Phase III
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality (galcanezumab-gnlm) in Episodic Cluster Headache
Phase III
ViiV Healthcare Announces Phase III Study Meets Primary Endpoint, Demonstrating the Ability to Control HIV-1 With the 2-drug Regimen Dovato in Virally Suppressed Patients...
Phase III
Biohaven’s Rimegepant Positive Phase 3 Trial For Acute Treatment Of Migraine Published In The New England Journal of Medicine
Phase III
First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy,...
Biospace News
-
July 8, 2019
0
Phase III
MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab...
Biospace News
-
July 3, 2019
0
Phase III
Boston Biomedical, Inc. Announces Update on Phase 3 CanStem111P Study of...
Biospace News
-
July 2, 2019
0
Phase III
Teva Presents Positive Results Showing Improvement in Disability and Quality of...
Biospace News
-
July 2, 2019
0
Phase III
Pfizer Announces Results from Phase 3 Trial of Revatio (Sildenafil Citrate)...
Firstwordpharma News
-
June 28, 2019
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
MOST POPULAR
No Increase in Ischaemic Events With Ticagrelor Monotherapy After 1 Month...
March 21, 2019
A Llama Antibody Could Be the Key to a Universal Flu...
November 2, 2018
Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual...
May 15, 2019
Report Highlights Positive Progress on Global Access to Medications
May 23, 2019
Load more
HOT NEWS
Others
Insys Therapeutics Files for Bankruptcy Following Legal Trouble
Commercial
GENFIT Seeks $132 Million IPO to Support NASH Programs
Deals
FDA and Flatiron Health Expand Real-World Data Cancer Research Collaboration
Commercial
Soligenix Receives US Patent for Dusquetide Related Analogs
